King International Investment Limited (0928.HK)
King International Investment Limited
Two Chinachem Exchange Square
Suite 2001, 20/F No.338 King’s Road
North Point
Hong Kong
https://www.kinginternational.hk
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 31
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Wai Lun Man | Executive Director | 126k | N/A | 1973 |
| Mr. Zhen Pang | Executive Director | 120k | N/A | 1976 |
| Mr. Mingqing Liu | CEO & Co-Chairman | N/A | N/A | 1980 |
| Mr. Mengyao Wang | Chairman | N/A | N/A | 1998 |
| Ms. Ching Yee Shum CPA | Chief Financial Officer | N/A | N/A | 1968 |
| Mr. Lei Ma | Chief Executive Officer - PRC | N/A | N/A | 1975 |
| Mr. Jianguo Gu | Executive Director | N/A | N/A | 1983 |
| Ms. Ming Yan | Executive Director | N/A | N/A | 1982 |
| Mr. Xingwu Lu | Executive Director | N/A | N/A | 1962 |
| Mr. Ka Sing Wong | Company Secretary | N/A | N/A | 1988 |
Description
King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in North Point, Hong Kong.
Corporate Governance
King International Investment Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
